Subscribe To
There's a silver lining in pfizer's dark cloud. should you buy the stock?
Pfizer reported an adjusted loss of nearly $1 billion in the third quarter, and recently lowered its fo...
November 3, 2023, 5:30 am
Should you still buy the nasdaq's best-performing october stocks?
Structure Therapeutics' weight-loss drug candidate is attracting attention over excitement about obesity treatments. ImmunityBio rallied on hopes that...
November 3, 2023, 5:20 am
Gold prices steady before nonfarm payrolls, weekly losses on tap
Investing.com– Gold prices steadied on Friday as traders hunkered down before key nonfarm payrolls data, with the yellow metal headed for a weekly...
November 3, 2023, 5:14 am
Warner bros. discovery: undervalued against peers as earnings are poised to rise
WBD continues to show net loss since the merger, but this scenario will soon change. It is generating F...
November 3, 2023, 4:39 am
Oil prices forecast: lower for second week amid middle east, china concerns
Crude oil prices steady, but risk of second weekly loss due to Middle East supply disruptions, China de...
November 3, 2023, 3:21 am
Aud/usd trades with modest intraday losses, hold above 0.6400 as traders keenly await us nfp
The AUD/USD pair extends the previous day’s late pullback from the 0.6455 area, or over a one-month high and remains under some selling pressure thr...
November 3, 2023, 1:44 am
Rosen, leading trial attorneys, encourages docgo inc. investors with losses to secure counsel before important deadline in securities class action – dcgo
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on...
November 3, 2023, 12:42 am
Clx loss alert: rosen, a leading law firm, encourages the clorox company investors to inquire about securities class action investigation – clx
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities cla...
November 3, 2023, 12:00 am
Sam bankman-fried's found guilty of defrauding ftx customers
The jury in FTX Founder Sam Bankman-Fried's trial has reached a verdict. Found guilty of defrauding FTX customers by jury in New YorkFound guilty on a...
November 2, 2023, 11:48 pm
Bitcoin miner northern data could float cloud unit, expects loss
Northern Data AG could float its cloud computing unit Taiga, the German bitcoin miner said Thursday as it unveiled a debt financing package to buy mor...
November 2, 2023, 9:14 pm
Oil prices steady, on track for second straight week of losses
Oil prices were little changed on Friday, heading for their second straight week of losses as the U.S. ...
November 2, 2023, 8:27 pm
Nl reports third quarter 2023 results
Dallas, Texas, Nov. 02, 2023 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today reported a net loss...
November 2, 2023, 8:20 pm
Puma biotech (pbyi) tops q3 earnings estimates
Puma Biotech (PBYI) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to
November 2, 2023, 7:32 pm
Mbia (mbi) reports q3 loss, tops revenue estimates
MBIA (MBI) came out with a quarterly loss of $2.92 per share versus the Zacks Consensus Estimate of a...
November 2, 2023, 7:32 pm
Udemy, inc. (udmy) q3 earnings and revenues top estimates
Udemy, Inc. (UDMY) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a...
November 2, 2023, 7:32 pm
Prothena (prta) beats q3 earnings and revenue estimates
Prothena (PRTA) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of a...
November 2, 2023, 7:32 pm
Cambium (cmbm) reports q3 loss, tops revenue estimates
Cambium (CMBM) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of...
November 2, 2023, 6:47 pm
Cytokinetics (cytk) reports q3 loss, misses revenue estimates
Cytokinetics (CYTK) came out with a quarterly loss of $1.35 per share versus the Zacks Consensus Estima...
November 2, 2023, 6:47 pm
Cerus (cers) reports q3 loss, lags revenue estimates
Cerus (CERS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a...
November 2, 2023, 6:47 pm
Ngm biopharmaceuticals (ngm) reports q3 loss, misses revenue estimates
NGM Biopharmaceuticals (NGM) came out with a quarterly loss of $0.35 per share versus the Zacks Consens...
November 2, 2023, 6:47 pm